IDNAvsIEFA
iShares Genomics Immunology and Healthcare ETF against iShares Core MSCI EAFE ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IDNA | IEFA | |
|---|---|---|
| Expense ratio | 0.47% | 0.070% |
| Assets | $219M | $193.2B |
| Net flow, 1 month | +$13M | +$631M |
| Net flow, 1 year | +$42M | +$17.9B |
| Return, YTD | +55.4% | +11.2% |
| Return, 1 year | +80.7% | +16.7% |
| Avg daily volume | 46K | 7.6M |
| Holdings | 63 | 2798 |
| Listed | Jun 10, 2019 | Oct 17, 2012 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS